Rodriguez Vicente J, Vicente Ortega V, Garcia Serrano F, Garcia Rojo B
Department of Pathology, Faculty of Medicine, University of Murcia, Spain.
Melanoma Res. 1993 Jun;3(3):195-202.
An experimental model is suggested for reproducing ocular melanoma in New Zealand white rabbits using B16 melanoma cells and protocols differing with respect to either tumour origin (subcutaneous fragments of melanoma B16 or B16-F10 tumour cell cultures) or implant site (the anterior chamber or subchoroidal). In 20 animals, 20 mg of methylprednisolone acetate was injected subconjunctivally as a local immunosuppressant. The only protocol resulting in tumour was inoculation of 4 x 10(6) B16-F10 melanocytes into the anterior chamber of the eye. Trans-scleral injections of cell suspensions produced tumour growth in 43% (13/30) of animals so treated. Thirteen animals developed non-neoplastic pigmented lesions formed of numerous melanophages. Another 19 animals showed non-pigmented lesions caused by reaction to the surgical procedures. Subconjunctivally injected methylprednisolone acetate did not increase the incidence of tumour growth.
提出了一种实验模型,用于在新西兰白兔中使用B16黑色素瘤细胞并根据肿瘤起源(黑色素瘤B16的皮下片段或B16-F10肿瘤细胞培养物)或植入部位(前房或脉络膜下)的不同方案来复制眼部黑色素瘤。在20只动物中,结膜下注射20mg醋酸甲泼尼龙作为局部免疫抑制剂。唯一导致肿瘤的方案是将4×10(6)个B16-F10黑色素细胞接种到眼的前房。经巩膜注射细胞悬液使43%(13/30)接受该处理的动物发生肿瘤生长。13只动物出现了由大量噬黑素细胞形成的非肿瘤性色素沉着病变。另外19只动物出现了由手术操作反应引起的无色素病变。结膜下注射醋酸甲泼尼龙并未增加肿瘤生长的发生率。